British regulatory authority approves Glucophage® Extended Release (XR) for type 2 diabetes patients with moderate renal impairment stage 3a or stable chronic heart failure The approval is based on ...
- Innovative Powder Formulation of Metformin Designed to Facilitate Adherence by Increasing Patient Choice in the Treatment of Type 2 Diabetes, Now Available in France and the United Kingdom FELTHAM, ...
Epidemiological, clinical and experimental evidence suggests a link between type 2 diabetes and Alzheimer's disease (AD). Insulin modulates metabolism of β-amyloid precursor protein (APP) in neurons, ...
Merck KGaA – known as EMD Serono in the US and Canada – has announced in a European work-sharing procedure (WSP) that an extension to the label for metformin products in the EU has been approved – ...
I have insulin resistance and have been using glucophage for the past 2 years now. I believe from what I read on this forum that glucophage also helps with ovulation - please confirm. Then, I'm also ...
A new study comparing three major diabetes drugs -- Avandia, Glucophage (metformin), and Micronase (glyburide) -- shows that all three drugs have pros and cons to consider. Patients and their doctors ...
Metformin, a generic diabetes treatment usually sold under the brand name Glucophage, may help people with diabetes to lose weight by lowering their appetites. Insulin makes people overweight by ...
In a European worksharing procedure (WSP), Glucophage® was approved as the firstoral anti-diabetic medication to be used safely from conception to birth. The approval was granted on the basis of Merck ...
Powdered versions of the diabetes medication Glucophage (metformin) are to be pulled in the UK due to unforeseen manufacturing issues, manufacturer Merck Serono Ltd has announced. The company has ...
Merck KGaA’s Glucophage, Concor and Euthyrox are three of its key products and the German drugmaker devotes a lot of resources to them, like a new plant in China to produce them for that market. Now ...
In a European worksharing procedure (WSP), Glucophage® was approved as the first oral anti-diabetic medication to be used safely from conception to birth. In a European worksharing procedure (WSP), ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results